Found 21 matching trials
Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
PHASE3The purpose of the present trial is to evaluate 6 vaccine formulations of r...
Location
GSK Clinical Trials Call Center
Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerixā¢-B in Healthy Volunteers ā„ 15y
PHASE3This study was conducted to evaluate the lot-to-lot consistency of three lo...
Location
GSK Clinical Trials Call Center
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
PHASE3This study compares the immunogenicity and safety of the novel adjuvanted H...
Location
Multiple Locations
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerixā¢-B in Healthy Adults (15-40 Yrs).
PHASE3This study evaluates the safety and immunogenicity of the candidate HBV-MPL...
Location
GSK Clinical Trials Call Center
Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerixā¢-B
PHASE3The purpose of the present trial is to assess the safety, reactogenicity an...
Location
GSK Clinical Trials Call Center
Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerixā¢-B, in Haemodialysis Patients
PHASE1This trial is designed to evaluate the immunogenicity, reactogenicity and s...
Location
GSK Clinical Trials Call Center
Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults
PHASE3In the present study the immunogenicity, reactogenicity and safety of recom...
Location
GSK Clinical Trials Call Center
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerixā¢-B in Healthy Adults Following 2 Different Schedules
PHASE2The purpose of this study is to evaluate the safety, immunogenicity and rea...
Location
GSK Clinical Trials Call Center
Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerixā¢-B in Adult Non-Responders
PHASE3The purpose of this study is to compare the immunogenicity and reactogenici...
Location
GSK Clinical Trials Call Center
Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerixā¢-B, in a Non-responder Population ā„ 15y
PHASE3Subjects who had not responded to previous hepatitis B vaccination were vac...
Location
Multiple Locations